Cibus, Inc. (CBUS)
(Delayed Data from NSDQ)
$9.85 USD
+0.36 (3.79%)
Updated Jun 28, 2024 04:00 PM ET
After-Market: $9.87 +0.02 (0.20%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth A Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CBUS 9.85 +0.36(3.79%)
Will CBUS be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for CBUS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CBUS
Cibus (CBUS) Reports Q1 Loss, Tops Revenue Estimates
Cibus (CBUS) Reports Q4 Loss, Tops Revenue Estimates (Revised)
CBUS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cibus (CBUS) Reports Q4 Loss, Tops Revenue Estimates
Cibus (CBUS) Moves 6.7% Higher: Will This Strength Last?
Alico (ALCO) Reports Q1 Loss, Tops Revenue Estimates
Other News for CBUS
Cibus Expands its Intellectual Property Coverage for Plant Gene Editing and Traits
Cibus expands intellectual property coverage for plant gene editing, traits
EXCLUSIVE: Cibus Expands Intellectual Property Coverage For 10 Plant Gene Editing And Trait Families
How To Profitably Hedge With Put Options
Cibus' Confirms Important Milestone for Nutrient Use Efficiency Trait Development